Clinical Trial Update: R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating R-(-)-Gossypol Acetic Acid in patients with recurrent extensive-stage small cell lung cancer has completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• R-(-)-Gossypol Acetic Acid (R-(-)-gossypol acetic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-03-21